Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004345 220001757 1.67 96.6 null 2013-02-23 2013-02-28 AML17 TRIAL Y N 220025856 AML17 TRIAL
220004346 220010871 1.75 null Disease modification (D) 2013-08-28 2013-08-28 Cytarabine Low Dose 2 N 220025857 CYTARABINE
220004347 220010871 1.63 71 Palliative (P) 2015-12-05 2015-12-10 Cytarabine Low Dose 02 null 220025857 CYTARABINE
220004348 220010871 1.59 98 null 2015-03-13 2015-03-13 AML17 TRIAL N null 220025857 AML17 TRIAL
220004349 220020261 1.79 62.3 Palliative (P) 2017-04-12 2017-04-25 Trial Unspecified Y N 220025862 TRIAL
220004350 220001758 1.75 79.8 Curative (C) 2014-04-09 2014-04-13 AML17 TRIAL Y N 220025866 AML17 TRIAL
220004351 220001758 1.86 81.4 Palliative (P) 2013-05-17 2013-05-17 AML17 TRIAL 01 N 220025866 AML17 TRIAL
220004352 220001758 null 75.4 Disease modification (D) 2016-07-07 2016-07-07 Cytarabine Low Dose N null 220025866 CYTARABINE
220004353 220001758 1.71 68 Curative (C) 2014-11-14 2014-11-14 AML17 TRIAL 01 N 220025866 AML17 TRIAL
220004354 220001759 1.48 64.4 Disease modification (D) 2014-03-12 2014-03-15 Trial Unspecified 01 N 220025874 TRIAL
220004355 220001759 1.77 null Disease modification (D) 2015-09-11 2015-09-11 Cytarabine low (10to20mg/m2) IV/SC N Y 220025874 CYTARABINE
220004356 220001759 1.73 81.4 Curative (C) 2017-07-23 2017-07-26 AML17 TRIAL N N 220025874 AML17 TRIAL
220004357 220018648 1.63 null Not known (9) 2014-11-13 2014-11-19 AML17 TRIAL Y N 220025885 AML17 TRIAL
220004358 220018648 1.5 null Disease modification (D) 2013-09-03 2013-09-03 Trial Unspecified Y null 220025885 TRIAL
220004359 220001760 1.65 74.5 null 2013-10-15 2013-10-18 Trial Unspecified Y N 220025888 TRIAL
220004360 220001761 1.65 61.5 Disease modification (D) 2017-09-15 2017-09-16 LI-1 TRIAL 1 N 220025891 TRIAL
220004361 220001761 null 0 Palliative (P) 2016-05-08 2016-05-08 Cytarabine Low Dose N N 220025891 CYTARABINE
220004362 220001761 null 81.4 Curative (C) 2014-05-01 2014-05-02 Trial Unspecified Y N 220025891 TRIAL
220004363 220001761 1.7 null Curative (C) null 2014-07-10 Cytarabine Low Dose null null 220025891 CYTARABINE
220004364 220001762 1.64 0 Curative (C) 2015-07-15 2015-07-19 Trial Unspecified 1 null 220025908 TRIAL
220004365 220001762 null null Disease modification (D) 2016-02-06 2016-03-19 Cytarabine Low Dose 2 N 220025908 CYTARABINE
220004366 220001762 1.72 78 Curative (C) 2013-02-11 2013-02-11 AML17 TRIAL 1 null 220025908 AML17 TRIAL
220004367 220001762 1.56 null Curative (C) null 2017-07-11 Trial Unspecified Y N 220025908 TRIAL
220004368 220001762 1.71 0 null 2014-11-14 2014-11-14 Cytarabine Low Dose 02 N 220025908 CYTARABINE
220004369 220001762 1.72 81 Palliative (P) 2013-05-18 2013-05-18 Cytarabine low (10to20mg/m2) IV/SC 2 N 220025908 CYTARABINE
220004370 220001762 1.58 62.3 null 2017-07-12 2017-07-13 Trial Unspecified 01 N 220025908 TRIAL
220004371 220021978 1.75 76.4 Curative (C) 2016-05-12 2016-05-12 AML17 TRIAL 02 N 220025922 AML17 TRIAL
220004372 220022145 1.7 54.899 Curative (C) 2017-03-12 2017-03-13 AML17 TRIAL N N 220025924 AML17 TRIAL
220004373 220022145 1.53 81.4 Not known (9) 2013-12-05 2013-12-05 AML17 TRIAL Y N 220025924 AML17 TRIAL
220004374 220022145 null 60.3 Curative (C) 2016-12-14 2016-12-17 LI-1 TRIAL Y N 220025924 TRIAL
220004375 220022314 1.7 null Curative (C) 2014-07-02 2014-07-02 Cytarabine Low Dose N N 220025933 CYTARABINE
220004376 220022314 1.68 null Palliative (P) 2013-07-20 2013-07-21 Cytarabine Low Dose N N 220025933 CYTARABINE
220004377 220001763 1.7 70.1 Palliative (P) 2014-03-25 2014-03-25 Cytarabine Low Dose 02 N 220025936 CYTARABINE
220004378 220001764 1.69 68.6 Curative (C) 2015-05-10 2015-05-10 Trial Unspecified 01 N 220025937 TRIAL
220004379 220001764 1.61 null Palliative (P) 2014-05-02 2014-05-03 Trial Unspecified Y N 220025937 TRIAL
220004380 220001764 null 80.9 Curative (C) 2016-02-09 2016-02-11 Trial Unspecified 01 N 220025937 TRIAL
220004381 220001764 1.67 82.7 Curative (C) 2013-01-24 2013-01-24 AML17 TRIAL 1 N 220025937 AML17 TRIAL
220004382 220001765 1.6 56.3 Curative (C) 2015-04-29 2015-05-01 AML17 TRIAL Y N 220025945 AML17 TRIAL
220004383 220010877 0 null Curative (C) 2013-04-04 2013-04-04 AML17 TRIAL 01 N 220025946 AML17 TRIAL
220004384 220010877 null null Disease modification (D) 2017-03-04 2017-03-04 Cytarabine Low Dose 02 N 220025946 CYTARABINE
220004385 220010877 1.67 68 Palliative (P) 2017-10-21 2017-10-21 CYTARABINE 2 null 220025946 CYTARABINE
220004386 220001766 1.52 65 null 2016-07-24 2016-08-05 AML17 TRIAL N N 220025950 AML17 TRIAL
220004387 220001766 1.73 76.7 Curative (C) 2015-05-24 2015-05-24 Trial Unspecified Y N 220025950 TRIAL
220004388 220001766 1.6 0 Curative (C) 2015-12-22 2015-12-22 AML17 TRIAL N N 220025950 AML17 TRIAL
220004389 220018653 1.7 92.4 Not known (9) null 2013-11-09 AML17 TRIAL Y null 220025956 AML17 TRIAL
220004390 220001767 1.89 89.25 Disease modification (D) 2013-04-01 2013-04-01 Cytarabine low (10to20mg/m2) IV/SC N N 220025957 CYTARABINE
220004391 220010879 1.74 null Curative (C) null 2017-06-03 AML17 TRIAL null null 220025959 AML17 TRIAL
220004392 220001768 1.86 null Curative (C) 2014-01-21 2014-01-22 Trial Unspecified Y null 220025960 TRIAL
220004393 220010880 null 82 Curative (C) 2017-08-15 2017-09-01 Trial Unspecified N N 220025962 TRIAL
220004394 220010880 null 89 Palliative (P) null 2017-09-30 Trial Unspecified N N 220025962 TRIAL